Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Ended earlyNCT00003530
What this trial is testing

Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Burzynski Research Institute 3
Not applicableNo Longer AvailableNCT00589030
What this trial is testing

Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
City of Hope Medical Center
Early research (Phase 1)Study completedNCT02204930
What this trial is testing

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Who this might be right for
Hemorrhage
Haemostatix Ltd 20
Not applicableLooking for participantsNCT05810402
What this trial is testing

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Who this might be right for
Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+2 more
University Hospital, Montpellier 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07836530
What this trial is testing

Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
BeOne Medicines 492
Not applicableUnknownNCT05781581
What this trial is testing

A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

Who this might be right for
Intestines CancerPulmonary CancerLiver Cancer+3 more
RenJi Hospital 50,000
Not applicableNot Yet RecruitingNCT07716345
What this trial is testing

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Not applicableUnknownNCT05118451
What this trial is testing

RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC

Who this might be right for
Primary Liver Cancers
Zhujiang Hospital 420
Early research (Phase 1)Study completedNCT02988440
What this trial is testing

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 20
Not applicableActive Not RecruitingNCT05165446
What this trial is testing

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Natalie Torok 35
Testing effectiveness (Phase 2)Study completedNCT01180959
What this trial is testing

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 45
Not applicableActive Not RecruitingNCT06140823
What this trial is testing

Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

Who this might be right for
Predictive Cancer Model
Beth Israel Deaconess Medical Center 6,000,000
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)Study completedNCT00006006
What this trial is testing

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)WithdrawnNCT00093548
What this trial is testing

Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center
Not applicableUnknownNCT03161925
What this trial is testing

Chinese Liver Cancer Clinical Survey

Who this might be right for
Primary Liver Cancer
Beijing Insight Science & Technology Co. Ltd. 5,000
Testing effectiveness (Phase 2)Study completedNCT04567615
What this trial is testing

Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cancer, Adult+2 more
Bristol-Myers Squibb 266
Early research (Phase 1)Study completedNCT00844168
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver Cancer+2 more
University of Washington 4
Next Page